Angene Chemical
Draw
|
Currency :
Home Products

AG00G3QJ

781613-23-8 | N-(3,4-dichloro-2-fluorophenyl)-6-methoxy-7-(((3aR,6aS)-2-methyloctahydrocyclopenta[c]pyrrol-5-yl)methoxy)quinazolin-4-amine

Chemical structure of N-(3,4-dichloro-2-fluorophenyl)-6-methoxy-7-(((3aR,6aS)-2-methyloctahydrocyclopenta[c]pyrrol-5-yl)methoxy)quinazolin-4-amine, CAS 781613-23-8
AG00G3QJ
sdsSDS
sdsCOA
TIP This product is typically in stock.Please contact us for quotation.
Request For Quotation

CAS Number 781613-23-8
Catalog Number AG00G3QJ(AGN-PC-0WCYBK)
Chemical Name N-(3,4-dichloro-2-fluorophenyl)-6-methoxy-7-(((3aR,6aS)-2-methyloctahydrocyclopenta[c]pyrrol-5-yl)methoxy)quinazolin-4-amine
IUPAC Name 7-[[(3aS,6aR)-2-methyl-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-5-yl]methoxy]-N-(3,4-dichloro-2-fluorophenyl)-6-methoxyquinazolin-4-amine
InChI InChI=1S/C24H25Cl2FN4O2/c1-31-9-14-5-13(6-15(14)10-31)11-33-21-8-19-16(7-20(21)32-2)24(29-12-28-19)30-18-4-3-17(25)22(26)23(18)27/h3-4,7-8,12-15H,5-6,9-11H2,1-2H3,(H,28,29,30)/t13?,14-,15+
InChI Key HVXKQKFEHMGHSL-GOOCMWNKSA-N
MDL Number MFCD23726660
Molecular Formula C24H25Cl2FN4O2
Molecular Weight 491.3853
SMILES CN1C[C@@]2([H])[C@@](C[C@@H](COC3=CC4=NC=NC(NC5=CC=C(Cl)C(Cl)=C5F)=C4C=C3OC)C2)([H])C1
UNII F6XM2TN5A1
Synonyms
EXEL-7647, N-(3,4-dichloro-2-fluorophenyl)-6-methoxy-7-(((3aR,6aS)-2-methyloctahydrocyclopenta(c)pyrrol-5-yl)methoxy)-4-quinazolinamine, tesevatinib, XL-647, XL647, Tesevatinib, XL647, XL-647, EXEL-7647, 781613-23-8, UNII-F6XM2TN5A1, KD-019, XL 647, F6XM2TN5A1, 651031-01-5, KD019, Tesevatinib [USAN:INN], EXEL 7647, 7-[[(3aS,6aR)-2-methyl-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-5-yl]methoxy]-N-(3,4-dichloro-2-fluorophenyl)-6-methoxyquinazolin-4-amine, KD 019, 1000599-06-3, C24H25Cl2FN4O2, SCHEMBL721992, SCHEMBL721993, SCHEMBL721994, GTPL7944, CHEMBL3544983, EX-A172, QCR-153, BCP23438, Tesevatinib;EXEL-7647;KD-019, 2809AH, KD-020, MFCD22124889, ZINC38912363, ZINC101781468, ZINC114456300, CS-3666, DB11973, SB11459, NCGC00390607-01, NCGC00390607-03, 4-Quinazolinamine, N-(3,4-dichloro-2-fluorophenyl)-6-methoxy-7-(((3aalpha,5beta,6aalpha)-octahydro-2-methylcyclopenta(c)pyrrol-5-yl)methoxy)-, HY-13314, N-(3,4-Dichloro-2-fluorophenyl)-6-methoxy-7-(((3ar,6as)-2-methyloctahydrocyclopenta(c)pyrrol-5-yl)methoxy)quinazolin-4-amine, AB0095021, Z-3098, 204618-EP2277867A2, 4-quinazolinamine, N-(3,4-dichloro-2-fluorophenyl)-6-methoxy-7-[[(3aa,5beta,6aa)-octahydro-2-methylcyclopenta[c]pyrrol-5-yl]methoxy]-, 7-[[(3aR,6aS)-2-methyl-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-5-yl]methoxy]-N-(3,4-dichloro-2-fluorophenyl)-6-methoxyquinazolin-4-amine, 7-{[(3aR,6aS)-2-methyl-hexahydro-1H-cyclopenta[c]pyrrol-5-yl]methoxy}-N-(3,4-dichloro-2-fluorophenyl)-6-methoxyquinazolin-4-amine, N-(3,4-dichloro-2-fluorophenyl)-6-methoxy-7-(((3aR,5r,6aS)-2-methyloctahydrocyclopenta[c]pyrrol-5-yl)methoxy)quinazolin-4-amine, N-(3,4-dichloro-2-fluorophenyl)-6-methoxy-7-{[(3ar,6as)-2-methylo Ctahydrocyclopenta[c]pyrrol-5-yl]methoxy}-4-quinazolinamine, N-(3,4-Dichloro-2-fluorophenyl)-6-methoxy-7-{[(3aR,6aS)-2-methyloctahydrocyclopenta[c]pyrrol-5-yl]methoxy}-4-quinazolinamine, N-(3,4-dichloro-2-fluorophenyl)-7-({[(3aR,5r,6aS)-2-methyloctahydrocyclopenta[c]pyrrol-5-yl]methyl}oxy)-6-(methyloxy)quinazolin-4-amine, XL-647, Primrose, D00ELE, D06WRF, cc-224, ACN-031569, CID10458325, CID 10458325, Renal system agent (polycystic kidney disease), Primrose, 781613-23-8 (or 874286-84-7), 4-Quinazolinamine, N-(3,4-dichloro-2-fluorophenyl)-6-methoxy-7-[[(3aa,5a,6aa)-octahydro- 2-methylcyclopenta[c]pyrrol-5-yl]methoxy]-, 4-Quinazolinamine, N-(3,4-dichloro-2-fluorophenyl)-6-methoxy-7-[[(3aalpha,5beta,6aalpha)-octahydro-2-methylcyclopenta[c]pyrrol-5-yl]methoxy]-, 40779-26-8, 874286-84-7,

Related Research Chemicals

    CERTIFICATE OF ANALYSIS
    Chemical Name: Batch Number:
    Chemical Structure: CAS Registry No:
    		Product ID:
    Manufacture Date:
    Storage Temperature:
    Formula:
    Molecular Weight:
    Quantity:
    Analysis Data:
    Test: Result:
    Conclusion: The above product meets the specifications of Angene.
    Analyst:Chase
    Date:
    Reviewed by:Jessie
    Date:
    Angene International Limited